Skip to content

house · Committee report

H. Rept. 118-260

HEALTH DATA ACCESS, TRANSPARENCY, AND AFFORDABILITY ACT OF 2023

2023-11-01

Committees

Associated legislation

Text

Committee Action

116TH CONGRESS Subcommittee Hearing on Examining Surprise Billing: Protecting Patients from Financial Pain On April 2, 2019, the Subcommittee on Health, Employment, Labor, and Pensions (HELP) held a hearing entitled ``Examining Surprise Billing: Protecting Patients from Financial Pain,'' which discussed hospital billing practices, including unexpected costs to consumers due, in part, to a lack of transparency in health care. Members and witnesses also discussed the need for more transparency in employer-sponsored plans to ensure plans can make informed decisions. The witnesses were Ms. Ilyse Schuman, Senior Vice President, Health Policy, American Benefits Council, Washington, D.C.; Dr. Jack Hoadley, Research Professor Emeritus, Health Policy Institute, Georgetown University Health Policy Institute, McCourt School of Public Policy, McLean, Virginia; Mr. Frederick Isasi, Executive Director, Families USA, Washington, D.C.; and Ms. Christen Linke Young, Fellow, USC-Brookings Schaeffer Initiative on Health Policy, Washington, D.C. Subcommittee Hearing on Making Health Care More Affordable: Lowering Drug Prices and Increasing Transparency On September 26, 2019, the HELP Subcommittee held a hearing entitled ``Making Health Care More Affordable: Lowering Drug Prices and Increasing Transparency,'' which examined the impact of rising prescription drug prices on workers and businesses and the need for greater transparency. Members and witnesses discussed how information on Pharmacy Benefit Managers' (PBMs) price negotiations with drug manufacturers are not provided to consumers. The witnesses were Mr. Frederick Isasi, Executive Director, Families USA, Washington, D.C.; Mr. David Mitchell, Founder, Patients for Affordable Drugs, Washington, D.C.; Ms. Bari Talente, Executive Vice President, National Multiple Sclerosis Society, Washington, D.C.; Dr. Mariana Socal, Assistant Scientist, Johns Hopkins University Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, Maryland; Mr. Christopher Holt, Director of Health Care Policy, American Action Forum, Washington, D.C.; and Dr. Craig Garthwaite, Associate Professor of Strategy, Northwestern University Kellogg School of Management, Evanston, Illinois. Full Committee Markup of H.R. 5800, the Ban Surprise Billing Act On February 11, 2020, the Committee met to mark up H.R. 5800, the Ban Surprise Billing Act, introduced by then-Chairman Bobby Scott (D-VA-3) and then-Ranking Member Foxx (R-NC-5). The legislation protected participants in employer-provided health plans from exorbitant out-of-network costs and included provisions improving transparency with respect to group health plan service providers, including those providing brokerage and consulting services. The Committee favorably reported the bill, as amended, by a recorded vote of 32 yeas and 13 nays. 117TH CONGRESS Subcommittee Hearing on Lower Drug Costs Now: Expanding Access to Affordable Health Care On May 5, 2021, the HELP Subcommittee held a hearing entitled ``Lower Drug Costs Now: Expanding Access to Affordable Health Care,'' which examined the causes of rising health care costs. The witnesses were Dr. Douglas Holtz-Eakin, President, American Action Forum, Washington, D.C.; Mr. Frederick Isasi, Executive Director, Families USA, Washington, D.C.; Mr. David Mitchell, Founder, Patients for Affordable Drugs, Washington, D.C.; and Dr. Mariana Socal, Assistant Scientist, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. The hearing included discussion regarding how the lack of PBM transparency contributes to higher costs for plans and consumers. Full Committee Hearing reviewing the President's Fiscal Year 2023 Budget Proposal for the Department of Health and Human Services On April 6, 2022, the Committee held a hearing entitled ``Examining the Policies and Priorities of the U.S. Department of Health and Human Services.'' The sole witness was the Honorable Xavier Becerra, Secretary of the U.S. Department of Health and Human Services (HHS), Washington, D.C. The lack of transparency in PBMs' activities and the impacts on health plans was discussed at the hearing. 118TH CONGRESS Subcommittee Hearing on Reducing Health Care Costs for Working Americans and Their Families On April 26, 2023, the HELP Subcommittee held a hearing entitled ``Reducing Health Care Costs for Working Americans and Their Families,'' which examined hospital billing practices, the need for increased transparency in health care, and lowering costs by expanding oversight of PBMs. Witnesses were Mr. Joel White, President, Council for Affordable Health Coverage, Washington, D.C.; Mrs. Tracy Watts, Senior Partner, Mercer, Washington, D.C.; Ms. Marcie Strouse, Partner, Capitol Benefits Group, Des Moines, Iowa; and Ms. Sabrina Corlette, J.D., Research Professor and Co-Director, Center on Health Insurance Reforms, Georgetown University McCourt School of Public Policy, Washington, D.C. Full Committee Hearing Examining the President's Fiscal Year 2024 Budget Proposal for the Department of Health and Human Services On June 13, 2023, the Committee held a hearing entitled ``Examining the Policies and Priorities of the U.S. Department of Health and Human Services.'' The sole witness was the Honorable Xavier Becerra, Secretary of HHS, Washington, D.C. Secretary Becerra spoke to the need for improved transparency of PBMs' activities. Subcommittee Hearing on Competition and Transparency: The Pathway Forward for a Stronger Health Care Market On June 21, 2023, the HELP Subcommittee held a hearing entitled ``Competition and Transparency: The Pathway Forward for a Stronger Health Care Market,'' which examined the need to improve competition and transparency in health care, including with respect to the activities of PBMs and third-party administrators (TPAs). The witnesses were Dr. Gloria Sachdev, President and CEO, Employers' Forum of Indiana, Carmel, Indiana; Ms. Sophia Tripoli, Senior Director of Health Policy and Director of the Center for Affordable Whole-Person Care, Families USA, Washington, D.C.; Mr. Greg Baker, CEO, AffirmedRx, Louisville, Kentucky; Ms. Christine Monahan, Assistant Research Professor, Center on Health Insurance Reforms, Georgetown University McCourt School of Public Policy, Washington, D.C.; and Mr. Juan Carlos ``JC'' Scott, President and CEO, Pharmaceutical Care Management Association, Washington, D.C. Full Committee Markup of H.R. 4527, the Health DATA Act On July 11, 2023, Rep. Lori Chavez-DeRemer (R-OR-5) introduced H.R. 4527, the Health DATA Act, with Reps. Mark Takano (D-CA-39) and Kathy Manning (D-NC-6) as original cosponsors. On July 12, 2023, the Committee met to mark up H.R. 4527 and reported it favorably, as amended, to the House of Representatives by a vote of 38 yeas and 1 nay. The Committee adopted an Amendment in the Nature of a Substitute offered by Rep. Chavez-DeRemer, which made technical changes to H.R. 4527. Committee Views STRENGTHENING THE GAG CLAUSE PROHIBITION Transparency requirements were enacted as part of the Consolidated Appropriations Act, 2021 (CAA).\2\ The CAA added Section 724 to ERISA,\3\ prohibiting gag clauses in contracts between health plans and issuers, health care providers, networks of providers, TPAs, and other service providers that restrict the plan or issuer from: obtaining cost or quality of care information; accessing de-identified claims data; or sharing information or data with a business associate. Plans and issuers must submit an annual attestation to the Departments of Labor, HHS, and the Treasury (jointly the tri- agencies) that they have complied with this requirement. In February, the tri-agencies issued guidance on the CAA's transparency provisions\4\ and created a website for the submission of attestations to the Centers for Medicare and Medicaid Services.\5\ --------------------------------------------------------------------------- \2\Pub. L. No. 116-260 (2020). \3\Parallel provisions were added to Section 9824 of the Internal Revenue Code and Section 2799A-9 of the Public Health Service Act. \4\https://www.dol.gov/sites/dolgov/files/EBSA/about-ebsa/our- activities/resource-center/faqs/aca-part-57.pdf. \5\https://www.cms.gov/cciio/programs-and-initiatives/other- insurance-protections/gag-clause-prohibition-compliance. --------------------------------------------------------------------------- Despite the changes made by the CAA, plan fiduciaries report they have not been able to obtain information that should be available under ERISA Section 724. Service providers, such as TPAs and PBMs, reportedly continue to erect barriers that limit plan fiduciaries from having full access to this data. Common restrictions include limitations on audits--such as the number and frequency of audits--that effectively make the data inaccessible. The responsibility under Section 724 is also misaligned; the prohibition on gag clauses is placed on the plan or issuer rather than on the service provider. The tri-agencies' guidance has compounded this problem by allowing service providers to submit the attestation on behalf of plans, even allowing for a single submission on behalf of multiple plans. During the HELP Subcommittee's June 21, 2023, hearing on ``Competition and Transparency: The Pathway Forward for a Stronger Health Care Market,'' Ms. Monahan encouraged Congress to examine ways to expand the gag clause prohibitions included in the CAA; Ms. Monahan also noted that TPAs currently are not required to eliminate gag clauses, placing the onus on employers to try to negotiate contracts without gag clauses.\6\ Ms. Sachdev highlighted that PBMs and TPAs often delay relaying information back to plan fiduciaries.\7\ She also spoke of successful efforts made in Indiana to combat these practices. --------------------------------------------------------------------------- \6\https://edworkforce.house.gov/uploadedfiles/ monahan_testimony.pdf. \7\https://edworkforce.house.gov/uploadedfiles/ sachdev_testimony.pdf. --------------------------------------------------------------------------- H.R. 4527, HEALTH DATA ACT OF 2023 H.R. 4527 eliminates any ambiguity in the CAA's requirements and ensures that the provisions function consistent with congressional intent. H.R. 4527 ensures the information that should be available to plan fiduciaries under ERISA Section 724 is available by prohibiting barriers that limit access to this data. H.R. 4527 will empower plan fiduciaries to access and use data and information that is necessary to monitor their agreements with service providers in order to provide higher quality and more affordable coverage in group health plans. H.R. 4527 Section-by-Section Summary Section 1. Short title Section 1 provides that the short title is ``Health Data Access, Transparency and Affordability Act (Health DATA Act).'' Section 2. Strengthening the gag clause Section 2(a) amends ERISA to provide that any contract or arrangement between a group health plan and any other entity (such as a health care provider, TPA, or PBM) is not reasonable within the meaning of the 408(b)(2) prohibited transaction exemption unless the responsible plan fiduciary is permitted to audit all de-identified claims and encounter information. A contract may not contain provisions that would: Limit the number of audits permitted during a period of time; Limit the number of claims and encounter data that a fiduciary may access during an audit; Limit the disclosure of pricing terms for value-based arrangements; Limit the disclosure of overpayments and overpayment recovery terms; Limit the right of the fiduciary to select an auditor; Delay the fiduciary by more than 60 days from auditing the information and data; or Charge a fee beyond the reasonable direct costs to conduct the audit. Section 2(b) authorizes the Secretary of Labor to assess a civil monetary penalty against an entity that violates the Health DATA Act of $10,000 per day for each day the violation continues. Section 3. Attestation Section 3 of the Health DATA Act strengthens the gag clause attestation by requiring that the group health plan attestation include a statement verifying that the information is available upon request, is issued in a timely manner, and does not delay the fiduciary from auditing the information. Section 3 also includes a safeguard that prevents a TPA from submitting the attestation on behalf of the plan, with an alternative submission option available in cases in which the plan or issuer is unable to submit the attestation. Section 4. Study on plan assets Section 4 requires the Secretary of Labor to submit a report to the Committee on Education and the Workforce of the House of Representatives on de-identified claims and encounter data, whether this data could be deemed a plan asset under ERISA, and whether the data belongs to a group health plan rather than a service provider. Application of Law to the Legislative Branch Explanation of Amendments The amendments, including the amendment in the nature of a substitute, are explained in the body of this report. Application of Law to the Legislative Branch Section 102(b)3 of Public Law 104-1 requires a description of the application of this bill to the legislative branch. H.R. 4527 takes important steps to preserve and expand access to affordable, high-quality health care by ensuring that group health plan fiduciaries have effective access to plan data. H.R. 4527 is applicable only to group health plans subject to ERISA and therefore does not affect the legislative branch. Unfunded Mandate Statement Pursuant to Section 423 of the Congressional Budget and Impoundment Control Act of 1974, Pub. L. No. 93-344 (as amended by Section 101(a)(2) of the Unfunded Mandates Reform Act of 1995, Pub. L. No. 104-4), the Committee adopts as its own the cost estimate prepared by the Congressional Budget Office (CBO) pursuant to section 402 of the Congressional Budget and Impoundment Control Act of 1974. Earmark Statement H.R. 4527 does not contain any congressional earmarks, limited tax benefits, or limited tariff benefits as defined in clause 9 of rule XXI of the Rules of the House of Representatives. Roll Call Votes Clause 3(b) of rule XIII of the Rules of the House of Representatives requires the Committee Report to include for each record vote on a motion to report the measure or matter and on any amendments offered to the measure or matter the total number of votes for and against and the names of the Members voting for and against. [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Statement of General Performance Goals and Objectives In accordance with clause (3)(c) of rule XIII of the Rules of the House of Representatives, the goal of H.R. 4527 is to preserve and expand access to affordable, high-quality health care by ensuring that plan fiduciaries have effective access to de-identified claims and encounter information for their group health plans. Duplication of Federal Programs No provision of H.R. 4527 establishes or reauthorizes a program of the Federal Government known to be duplicative of another Federal program, a program that was included in any report from the Government Accountability Office to Congress pursuant to section 21 of Public Law 111-139, or a program related to a program identified in the most recent Catalog of Federal Domestic Assistance. Statement of Oversight Findings and Recommendations of the Committee In compliance with clause 3(c)(1) of rule XIII and clause 2(b)(1) of rule X of the Rules of the House of Representatives, the committee's oversight findings and recommendations are reflected in the body of this report. Required Committee Hearing and Related Hearings In compliance with clause 3(c)(6) of rule XIII of the Rules of the House of Representatives the following hearings held during the 118th Congress were used to develop or consider H.R. 4527: on April 26, 2023, the HELP Subcommittee held a hearing entitled ``Reducing Health Care Costs for Working Americans and Their Families;'' on June 13, 2023, the Committee held a hearing entitled ``Examining the Policies and Priorities of the U.S. Department of Health and Human Services;'' and on June 21, 2023, the HELP Subcommittee held a hearing entitled ``Competition and Transparency: The Pathway Forward for a Stronger Health Care Market.'' New Budget Authority and CBO Cost Estimate With respect to the requirements of clause 3(c)(2) of rule XIII of the Rules of the House of Representatives and section 308(a) of the Congressional Budget Act of 1974 and with respect to requirements of clause 3(c)(3) of rule XIII of the Rules of the House of Representatives and section 402 of the Congressional Budget Act of 1974, the Committee requested a cost estimate from the Congressional Budget Office. The Committee adopts the following estimate for H.R. 4527 provided by the Congressional Budget Office to Majority staff via email on September 12, 2023: ``We estimate no effect on direct spending or revenues for H.R. 4527 (Health DATA Act of 2023), with time stamp July 10, 2023 at 3:42pm).'' Committee Cost Estimate Clause 3(d)(1) of rule XIII of the Rules of the House of Representatives requires an estimate and a comparison of the costs that would be incurred in carrying out H.R. 4527. However, clause 3(d)(2)(B) of that rule provides that this requirement does not apply when, as with the present report, the committee adopts as its own the cost estimate of the bill prepared by the Congressional Budget Office under section 402 of the Congressional Budget Act. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 * * * * * * * TITLE I--PROTECTION OF EMPLOYEE BENEFIT RIGHTS * * * * * * * Subtitle B--Regulatory Provisions * * * * * * * Part 4--Fiduciary Responsibility * * * * * * * EXEMPTIONS FROM PROHIBITED TRANSACTIONS Sec. 408. (a) The Secretary shall establish an exemption procedure for purposes of this subsection. Pursuant to such procedure, he may grant a conditional or unconditional exemption of any fiduciary or transaction, or class of fiduciaries or transactions, from all or part of the restrictions imposed by sections 406 and

Source: https://api.congress.gov/v3/committee-report/118/hrpt/260